Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Achieve Life Sciences Inc shares valued at $38,974 were sold by Wan Jerry on Sep 04 ’25. At $2.77 per share, Wan Jerry sold 14,070 shares. The insider’s holdings dropped to 32,694 shares worth approximately $96774.24 following the completion of this transaction.
Also, KING THOMAS BRAXTON sold 139,858 shares, netting a total of over 387,407 in proceeds. Following the sale of shares at $2.77 each, the insider now holds 315,142 shares.
Before that, JACOBS CINDY had sold 27,629 shares from its account. In a trade valued at $76,532, the President & CMO traded Achieve Life Sciences Inc shares for $2.77 each. Upon closing the transaction, the insider’s holdings decreased to 27,629 shares, worth approximately $0.34 million.
As published in their initiating research note from H.C. Wainwright on August 21, 2025, Achieve Life Sciences Inc [ACHV] has been a Buy and the price target has been revised to $12. Analysts at Rodman & Renshaw started covering the stock with ‘”a Buy”‘ outlook in a report released in mid November. As of September 27, 2024, Raymond James has initiated its “Strong buy” rating for ACHV. Earlier on May 10, 2023, Maxim Group resumed its rating. Their recommendation was “a Buy” for ACHV stock.
Analyzing ACHV Stock Performance
On last trading session, Achieve Life Sciences Inc [NASDAQ: ACHV] plunged -3.90% to $2.96. The stock’s lowest price that day was $2.96, but it reached a high of $3.09 in the same session. During the last five days, there has been a drop of approximately -9.76%. Over the course of the year, Achieve Life Sciences Inc shares have dropped approximately -34.66%.
Is Achieve Life Sciences Inc subject to short interest?
Stocks of Achieve Life Sciences Inc saw a sharp rise in short interest on 2025-08-29 jumping by 2.39 million shares to 5.18 million. Data from Yahoo Finance shows that the short interest on 2025-07-31 was 2.79 million shares. A jump of 46.18% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.64 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.64.
Which companies own the most shares of Achieve Life Sciences Inc (ACHV)?
In terms of Achieve Life Sciences Inc share price expectations, FactSet research, analysts set an average price target of 4.75 in the next 12 months, up nearly 54.22% from the previous closing price of $3.08. Analysts anticipate Achieve Life Sciences Inc stock to reach 5.5 by 2025, with the lowest price target being 4. In spite of this, 2 analysts ranked Achieve Life Sciences Inc stock as Buy at the end of 2025. On June 23, 2021, Oppenheimer assigned a price target of “an Outperform” to the stock and initiated coverage with a $23.